Richa Tripathi, MD
Neurology · Morgantown, WVNPI 1528409133
Payments from drug & device makers
What this record shows
This record is dominated by grants: $6,250 of the $8,181 with a category attached, or 76.4%. Medtronic accounts for 97.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $6,250 and has fallen 99.6% since, to $28 in 2025.
Across 19 payments — averaging $430.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$150
- Insightec,inc$28
- Abbott$26
- Biogen$16
What the payments were for
- Grants$6,25076%
- Travel & lodging$1,61920%
- Food & beverage$3124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $7,962 |
| Boston Scientific | 1 | $150 |
| Insightec,inc | 1 | $28 |
| Abbott | 1 | $26 |
| Biogen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,181 in reported general payments places this provider in the 75th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 27 | $256,459 |
| IngrezzaValbenazine Tosylate | 12 | $105,063 |
| GocovriAmantadine Hcl | 19 | $73,325 |
| RytaryCarbidopa/Levodopa | 61 | $52,384 |
| MyrbetriqMirabegron | 93 | $48,657 |
| NeuproRotigotine | 28 | $24,575 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 388 | $15,174 |
| Entacapone | 36 | $6,447 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 70 | $3,741 |
| AmantadineAmantadine Hcl | 48 | $3,702 |
| Midodrine Hcl | 19 | $2,632 |
| Donepezil Hcl | 163 | $1,653 |
| Propranolol Hcl ErPropranolol Hcl | 47 | $1,291 |
| RivastigmineRivastigmine Tartrate | 42 | $1,185 |
| Primidone | 25 | $925 |
Paid to pharmacies, not to this prescriber.
Other neurology in Morgantown
- Umer NajibMorgantown$246K
- Cheryl SmithMorgantown$68K
- Mouhannad AzzouzMorgantown$40K
- Maria Moreno EscobarMorgantown$23K
- Shumaila SultanMorgantown$13K
- Ann MurrayMorgantown$12K
- Violina MelnicMorgantown$12K
- Melanie WardMorgantown$9K
- Phong VuMorgantown$5K
- Ruchi DhyaniMorgantown$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.